Encyclopedic Tumor Analysis Guided Treatments with Conventional Drugs Outperform Available Alternatives in Refractory Head and Neck Cancers

We present findings from the HNSCC sub-cohort of the pan-cancer RESILIENT trial where patients with advanced refractory disease were treated with ETA guided treatments regimens.

Source: International Journal of Radiation Oncology * Biology * Physics - March 12, 2020 Category: Radiology Authors: D. Akolkar, D. Patil, T. Crook, C. Sims, V. Datta, R. Patil, P. Fulmali, P. Devhare, S. Apurwa, A. Srinivasan, R. Datar Tags: Poster Theater Presentations Source Type: research